The News Review:
- InMotion Invests In RSA Research
- Gene therapy safety trial for childhood blindness under way
- Netherlands Corporate News – Medidata Solutions realiseert groei voor…
- Lingle releases $1.2M for Leahi Hospital upgrades
- HEALTH BRIEFS | www.gulfbreezenews.com | Gulf Breeze News
InMotion Invests In RSA Research
Memphis Daily News – Nov 21, 2007
Questions like: ‘Did my hip modification work?’ r ‘How did my new polyethylene compound endure?’That will come when the InMotion Musculoskeletal Institute becomes just the second center in the United States to offer Radio Stereometric Analysis (RSA) for clinical research. “There are other places in the country with RSA but they’re not using it for solving patient problems” said Ruxandra Marinescu manager of the Medtronic Biomechanics Library at InMotion. “nly in Boston are they using RSA for clinical research. “The technology is not new and has been available in Europe more than 20 years. The difference is cultural; American academic research is very fluid with people moving about to work on new projects. It encourages innovation and creativity but at least in the case of RSA has been a barrier to forming critical mass. “It takes about six critical pieces that need to come together at the same time” Marinescu said.
Gene therapy safety trial for childhood blindness under way
Hindu – Nov 21, 2007
and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals. It’s been six years since a multi-university team used gene therapy to give sight to puppies born with a defect that causes blindness according to Eurekalert the news service of the American Association for the Advancement of Science. Now the gene-transfer technique is being tested for safety in people in a phase 1 clinical research study conducted by the University of Pennsylvania and the University of Florida with support from the National Eye Institute of the National Institutes of Health. A young adult with a form of hereditary blindness called Leber congenital amaurosis type 2 or LCA2 received an injection of trillions of replacement genes into the retina of one eye this month making the volunteer one of the first people in the world to undergo the procedure.
Netherlands Corporate News – Medidata Solutions realiseert groei voor…
Netherlands Corporate News – Netherlands Corporate News (persbericht) – Nov 21, 2007
Medidata CE Tarek Sherif was also named among the PharmaVICE 100 list of the top inspirational people in the life sciences industry. — Global speaking engagements: Medidata executives delivered presentations at a range of industry events including CDISC 2007 Interchange The Center for Business Intelligence 10th Registries and Post Approval Studies Congress The Regulatory Compliance Workshop Groups Solving the Problems in Designing Implementing and Managing SPs for Clinical Research Pharmaceutical Contract Management Group (PCMG) and Association for Clinical Data Management (ACDM) Meeting and the Society for Data Management 2007 Fall Conference. “During this quarter Medidata Solutions has made impressive gainsthrough notable customers wins and extended relationships withexisting customers” said Tarek Sherif CE of Medidata Solutions. “Inaddition to our expanding client and partner base due to the successof Medidata Rave the industry-leading EDC management and reportingsolution we have also continued paving the way for innovation inadaptive clinical trials Late Phase trials and beyond – all of whichare vital to enabling life sciences companies to safely andefficiently improve quality of life. About Medidata Solutions Worldwide Medidata Solutions helps the world’s leading pharmaceuticalbiotechnology medical device and research organizations maximize thevalue of their clinical research investments. Innovative processdesign technology and services streamline clinical trials byproviding early visibility to reliable clinical data – the lifebloodof every research organization… “During this quarter Medidata Solutions has made impressive gainsthrough notable customers wins and extended relationships withexisting customers” said Tarek Sherif CE of Medidata Solutions. “Inaddition to our expanding client and partner base due to the successof Medidata Rave the industry-leading EDC management and reportingsolution we have also continued paving the way for innovation inadaptive clinical trials Late Phase trials and beyond – all of whichare vital to enabling life sciences companies to safely andefficiently improve quality of life. About Medidata Solutions Worldwide Medidata Solutions helps the world’s leading pharmaceuticalbiotechnology medical device and research organizations maximize thevalue of their clinical research investments. Innovative processdesign technology and services streamline clinical trials byproviding early visibility to reliable clinical data – the lifebloodof every research organization. Working with companies andinstitutions both large and small Medidata Solutions helps clinicalresearchers safely accelerate the process of bringing life-enhancingtreatments to market – on six continents and in more than 80countries. Medidata Solutions brings significant value to its broadclient base with deep clinical experience and expertise in more than20 therapeutic areas projects in Phase I II III IV registries andsurveillance and studies with thousands of investigators andtens-of-thousands of subjects. For more information please visitwww.
Lingle releases $1.2M for Leahi Hospital upgrades
Honolulu Advertiser – Nov 21, 2007
“These improvements will ensure that the hospital continues to operate efficiently and effectively and that patients and staff are well-served. ” About $512670 will fund the construction of a new roof for the hospital’s Atherton Building to prevent further leaking and protect equipment and records from water damage. The building houses HHSC’s administrative staff and clinical research offices of the University of Hawai’i-Manoa John A. Burns School of Medicine. About $703820 will be used to replace two elevator cabs in the hospital’s Young Building which serves as the residence area for long-term care patients and is used by visitors and hospital staff. The design phase for both projects will be completed in December. Construction for the Atherton Building is scheduled to begin in spring and be completed by December 2008.
HEALTH BRIEFS | www.gulfbreezenews.com | Gulf Breeze News
Gulf Breeze News – Nov 21, 2007
Men and women who have been diagnosed with diabetic neuropathy ages 18 to 70 with a blood glucose level no greater than 300 should apply. Those responding will be screened further to determine eligibility. Those eligible will take part in a 20-week study that includes six visits at Baptist Clinical Research study center. Study related medical and lab procedures will be performed at no cost. Call Baptist Clinical Research at 850-469- 2491 to be screened for participation in this study. Health screenings at St. Ann Residents living in and around Gulf Breeze can be screened to reduce their risk of having a stroke or a serious bone fracture… Those eligible will take part in a 20-week study that includes six visits at Baptist Clinical Research study center. Study related medical and lab procedures will be performed at no cost. Call Baptist Clinical Research at 850-469- 2491 to be screened for participation in this study. Health screenings at St. Ann Residents living in and around Gulf Breeze can be screened to reduce their risk of having a stroke or a serious bone fracture. Life Line Screening will be at St. Ann Catholic Church on Dec.
